Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BNGO
BNGO logo

BNGO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bionano Genomics Inc (BNGO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.140
1 Day change
-1.72%
52 Week Range
5.500
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BNGO is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading essentially flat around $1.15 with mixed-to-bearish technicals, no recent news catalyst, no strong institutional or insider buying, and no compelling financial update available to support a long-term entry. The only clearly positive item is a bullish MACD shift, but it is not enough to override the bearish moving-average structure and lack of momentum confirmation. For an impatient investor, this is not a strong buy today.

Technical Analysis

BNGO is in a weak and indecisive trend. The price is near the pivot at 1.152, with R1 at 1.178 and S1 at 1.125, showing a very tight near-term range. MACD histogram is slightly positive and expanding, which is a mild bullish sign, but RSI_6 at 48.788 is neutral and does not show strong demand. The moving average structure is bearish, with SMA_200 > SMA_20 > SMA_5, indicating the broader trend remains down. The short-term price action is close to flat, and the modeled trend probabilities are also weak, with only a 50% chance of small moves and a slight negative bias over the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment data is not very informative here because the reported put-call ratios are both 0.0, and there is no meaningful call/put volume or open-interest detail available. Historical volatility is very high at 144.61, which suggests large potential price swings, but without supportive flow data this does not create a clear bullish signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
13
Buy
0

Positive Catalysts

  • ["MACD histogram is above zero and expanding, suggesting some short-term improvement in momentum.", "Analyst H.C. Wainwright still keeps a Buy rating.", "Price is hovering near pivot support, which could allow a small bounce if buyers step in."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh event-driven catalyst.", "Bearish moving-average alignment indicates the longer-term trend is still weak.", "Analyst price target was cut from $7 to $6 due to increased share count, showing reduced enthusiasm.", "Hedge funds are neutral and insiders are neutral, with no significant buying trend.", "No recent congress trading data and no notable politician/influencer transactions were reported.", "The stock trend model suggests only limited upside and a slight negative bias over the next month."]

Financial Performance

No usable latest-quarter financial snapshot was provided because of an error, so there is no reliable recent quarterly growth update to support a long-term buy thesis. The latest quarter season cannot be determined from the supplied data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst trend is mixed but still broadly positive on paper: H.C. Wainwright lowered the price target to $6 from $7 while maintaining a Buy rating. The cut reflects dilution from increased share count, which is a negative signal for valuation. Wall Street’s bull case is that the stock still has upside from current levels if execution improves, while the bear case is that the lower target, dilution, weak trend, and lack of momentum make the name unattractive for a beginner long-term buyer right now.

Wall Street analysts forecast BNGO stock price to rise
2 Analyst Rating
Wall Street analysts forecast BNGO stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.160
sliders
Low
7
Averages
7.5
High
8
Current: 1.160
sliders
Low
7
Averages
7.5
High
8
H.C. Wainwright
Buy
downgrade
$7 -> $6
AI Analysis
2026-04-13
Reason
H.C. Wainwright
Price Target
$7 -> $6
AI Analysis
2026-04-13
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Bionano Genomics to $6 from $7 and keeps a Buy rating on the shares. The firm cites the company's increased share count for the target cut.
H.C. Wainwright
Buy
downgrade
$11 -> $7
2025-11-24
Reason
H.C. Wainwright
Price Target
$11 -> $7
2025-11-24
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Bionano Genomics to $7 from $11 and keeps a Buy rating on the shares. The firm adjusted the company's model post the Q3 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BNGO
Unlock Now

People Also Watch